ASTech Co., Ltd.
Financials
Valuation Metrics
ASTech Co., Ltd.'s Market Cap is ₩428B. At end of 2025 it was ₩1038B. Ranked #1813 of 2,405 in KR market (top 75%), #1114 of 1,627 on KOSDAQ (top 68%), #214 of 292 in Materials (top 73%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 42.79B KRW | KR#1,813/2,405 Sec#214/292 |
| Revenue | 19.46B KRW | KR#2,136/2,405 Sec#282/292 |
| Net Income | -6.69B KRW | KR—/2,405 Sec—/292 |
| Total Assets | 111.34B KRW | KR#1,690/2,405 Sec#229/292 |
| Net Assets | 65.42B KRW | KR#1,730/2,405 Sec#235/292 |
| Employees | 43 | KR#2,098/2,405 Sec#260/292 |
| Value | ||
| P/B | 0.65x | KR#1,125/2,405 Sec#199/292 |
| P/S | 2.20x | KR#1,885/2,405 Sec#270/292 |
| FCF Yield | -65.53% | KR—/2,405 Sec—/292 |
| Profitability | ||
| ROE | -10.23% | KR#1,940/2,405 Sec#259/292 |
| ROA | -6.01% | KR#1,971/2,405 Sec#263/292 |
| Op. Margin | -42.86% | KR#2,201/2,405 Sec#285/292 |
| Revenue Growth | -34.68% | KR#2,232/2,405 Sec#287/292 |
| Earnings Growth | -258.69% | KR#1,258/2,405 Sec#159/292 |
| Financial Health | ||
| Debt Ratio | 70.18% | KR#1,213/2,405 Sec#147/292 |
| Total Debt | 42.87B KRW | KR#1,060/2,405 Sec#171/292 |
| FCF | -28.04B KRW | KR#1,962/2,405 Sec#241/292 |
| Cash | 13.44B KRW | KR#1,507/2,405 Sec#185/292 |
| Current Ratio | 0.59x | KR#2,079/2,405 Sec#264/292 |
| Dividend | ||
| Div. Yield | 7.36% | KR#118/2,405 Sec#20/292 |
| Performance | ||
| 1Y Return | -57.73% | KR#2,109/2,405 Sec#268/292 |
| 1M Return | -9.54% | KR#1,118/2,405 Sec#150/292 |
| From 52W High | -61.40% | KR#1,718/2,405 Sec#238/292 |
| 1Y MDD | -62.87% | KR#1,613/2,405 Sec#230/292 |
| Trading | ||
| Volume | 2,504 shares | KR#2,245/2,405 Sec#263/292 |
| Trading Value | 16.4M KRW | KR#2,144/2,405 Sec#253/292 |
| Foreign Own. | 13.05% | KR#372/2,405 Sec#41/292 |
| Per Share | ||
| EPS | -1,038 KRW | KR—/2,405 Sec—/292 |
| BPS | 10,152 KRW | KR#992/2,405 Sec#149/292 |
Company Info
AESTEK, established in 2005, specializes in the production of chemical raw materials, particularly ultraviolet blocking agents, and received KOSDAQ listing approval in 2023. The company built its business foundation in 2008 by partnering with Samjin Pharmaceutical for technology transfer and material supply. AESTEK produces sunblock raw materials and pharmaceuticals, growing into a specialized materials, parts, and equipment company through technology development and patent acquisition. The company is headquartered in Seocheon-gun, Chungcheongnam-do.